TPA Yuzu Health Aims to Revamp Health Benefits with $35M Boost
Yuzu’s $35 million round was led by General Catalyst and Chemistry, with participation from Anthropic’s Anthology Fund, Bain Future Back Ventures, Timeless Ventures, Lachy Groom and Neo.
Yuzu’s $35 million round was led by General Catalyst and Chemistry, with participation from Anthropic’s Anthology Fund, Bain Future Back Ventures, Timeless Ventures, Lachy Groom and Neo.
Daffodil’s Series A round was led by Flare Capital Partners, with participation from LRVHealth and Maverick Ventures.